AG˹ٷ

STOCK TITAN

[Form 4] Align Technology Inc Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Viavi Solutions Inc. (VIAV) has filed a Form 144 disclosing that former CEO and current chairman Richard E. Belluzzo intends to sell 8,385 common shares through Morgan Stanley on or after 01 Aug 2025. Based on the form’s stated market value of $81,500, the proposed sale equals roughly 0.0038 % of the 223.2 million shares outstanding, making the transaction immaterial to the public float.

The notice also details Belluzzo’s recent trading history: over the past three months he sold 25,155 shares in seven trades, yielding approximately $234.8 k in gross proceeds. All shares derive from restricted stock granted on 22 Feb 2017; no cash was paid at acquisition.

The filing contains no financial results, guidance, or operational updates. Form 144 merely signals an intention to sell and does not guarantee execution or imply new information about Viavi’s fundamentals.

Viavi Solutions Inc. (VIAV) ha presentato un modulo 144 comunicando che l'ex CEO e attuale presidente Richard E. Belluzzo intende vendere 8.385 azioni ordinarie tramite Morgan Stanley a partire dal 01 agosto 2025. In base al valore di mercato indicato nel modulo, pari a 81.500 $, la vendita proposta corrisponde a circa lo 0,0038 % delle 223,2 milioni di azioni in circolazione, rendendo la transazione irrilevante per il flottante pubblico.

Il comunicato dettaglia anche la recente attività di trading di Belluzzo: negli ultimi tre mesi ha venduto 25.155 azioni in sette operazioni, ottenendo circa 234.800 $ di proventi lordi. Tutte le azioni derivano da azioni vincolate assegnate il 22 febbraio 2017; non è stato pagato denaro al momento dell'acquisizione.

Il modulo non contiene risultati finanziari, previsioni o aggiornamenti operativi. Il modulo 144 indica solo l’intenzione di vendere e non garantisce l’esecuzione né implica nuove informazioni sui fondamentali di Viavi.

Viavi Solutions Inc. (VIAV) ha presentado un Formulario 144 informando que el ex CEO y actual presidente Richard E. Belluzzo tiene la intención de vender 8,385 acciones ordinarias a través de Morgan Stanley a partir del 01 de agosto de 2025. Según el valor de mercado declarado en el formulario, de 81.500 $, la venta propuesta representa aproximadamente el 0,0038 % de las 223,2 millones de acciones en circulación, haciendo que la transacción sea insignificante para el flotante público.

El aviso también detalla la actividad reciente de Belluzzo: en los últimos tres meses vendió 25,155 acciones en siete operaciones, generando aproximadamente 234,800 $ en ingresos brutos. Todas las acciones provienen de acciones restringidas otorgadas el 22 de febrero de 2017; no se pagó efectivo en la adquisición.

El formulario no contiene resultados financieros, pronósticos ni actualizaciones operativas. El Formulario 144 solo señala la intención de vender y no garantiza la ejecución ni implica nueva información sobre los fundamentos de Viavi.

Viavi Solutions Inc. (VIAV)� � CEO이자 � 회장� Richard E. Belluzzo가 2025� 8� 1� 이후 Morgan Stanley� 통해 8,385 보통주를 매도� 계획임을 알리� Form 144� 제출했습니다. 양식� 명시� 시장 가� 81,500달러� 기준으로 하면, 제안� 매도� 전체 발행 주식 2� 2,320� 주의 � 0.0038%� 해당하여 공공 유통 주식에는 미미� 영향입니�.

통지서에� Belluzzo� 최근 거래 내역� 포함되어 있습니다: 지� 3개월� 7건의 거래� 통해 25,155주를 매도하여 � 234,800달러� � 수익� 얻었습니�. 모든 주식은 2017� 2� 22일에 부여된 제한 주식에서 나왔으며, 취득 � 현금 지급은 없었습니�.

� 제출 서류에는 재무 실적, 전망 또는 운영 업데이트가 포함되어 있지 않습니다. Form 144� 단순� 매도 의사� 나타내며, 실행� 보장하거� Viavi� 기본 사항� 대� 새로� 정보� 의미하지 않습니다.

Viavi Solutions Inc. (VIAV) a déposé un formulaire 144 indiquant que l'ancien PDG et actuel président Richard E. Belluzzo prévoit de vendre 8 385 actions ordinaires via Morgan Stanley à partir du 1er août 2025. Selon la valeur de marché indiquée dans le formulaire, soit 81 500 $, la vente proposée représente environ 0,0038 % des 223,2 millions d'actions en circulation, rendant la transaction insignifiante pour le flottant public.

L'avis détaille également l'historique récent des transactions de Belluzzo : au cours des trois derniers mois, il a vendu 25 155 actions en sept transactions, générant environ 234 800 $ de produit brut. Toutes les actions proviennent d'actions restreintes attribuées le 22 février 2017 ; aucun paiement en espèces n'a été effectué lors de l'acquisition.

Le dépôt ne contient aucun résultat financier, prévision ou mise à jour opérationnelle. Le formulaire 144 signale uniquement une intention de vente et ne garantit pas l'exécution ni n'implique de nouvelles informations sur les fondamentaux de Viavi.

Viavi Solutions Inc. (VIAV) hat ein Formular 144 eingereicht, in dem der ehemalige CEO und aktuelle Vorsitzende Richard E. Belluzzo beabsichtigt, 8.385 Stammaktien über Morgan Stanley ab dem 01. August 2025 zu verkaufen. Basierend auf dem im Formular angegebenen Marktwert von 81.500 $ entspricht der geplante Verkauf etwa 0,0038 % der 223,2 Millionen ausstehenden Aktien, was die Transaktion für den Streubesitz unbedeutend macht.

Die Mitteilung enthält auch Belluzzos jüngste Handelsaktivitäten: In den letzten drei Monaten verkaufte er 25.155 Aktien in sieben Transaktionen und erzielte dabei einen Bruttoerlös von etwa 234.800 $. Alle Aktien stammen aus eingeschränkten Aktien, die am 22. Februar 2017 gewährt wurden; beim Erwerb wurde kein Geld bezahlt.

Die Einreichung enthält keine Finanzergebnisse, Prognosen oder betriebliche Updates. Formular 144 signalisiert lediglich die Verkaufsabsicht und garantiert weder die Ausführung noch impliziert es neue Informationen über die Fundamentaldaten von Viavi.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small insider sale (0.0038 % float); neutral for valuation.

Belluzzo’s potential $81 k sale is negligible relative to VIAV’s market capitalization and follows modest selling activity earlier this quarter. There is no accompanying business disclosure, so the filing neither strengthens nor weakens the investment thesis. Insider selling can sometimes foreshadow caution, but the size and frequency here appear consistent with routine diversification. I see no material impact on earnings, liquidity, or share supply.

TL;DR: Routine Rule 144 notice; governance implications minimal.

The company continues to follow proper disclosure protocols. All sales are aggregated as required, and the representation that no undisclosed adverse information exists aligns with best-practice compliance. The limited share count and transparent broker arrangement suggest standard portfolio management rather than a strategic exit. Governance risk remains unchanged.

Viavi Solutions Inc. (VIAV) ha presentato un modulo 144 comunicando che l'ex CEO e attuale presidente Richard E. Belluzzo intende vendere 8.385 azioni ordinarie tramite Morgan Stanley a partire dal 01 agosto 2025. In base al valore di mercato indicato nel modulo, pari a 81.500 $, la vendita proposta corrisponde a circa lo 0,0038 % delle 223,2 milioni di azioni in circolazione, rendendo la transazione irrilevante per il flottante pubblico.

Il comunicato dettaglia anche la recente attività di trading di Belluzzo: negli ultimi tre mesi ha venduto 25.155 azioni in sette operazioni, ottenendo circa 234.800 $ di proventi lordi. Tutte le azioni derivano da azioni vincolate assegnate il 22 febbraio 2017; non è stato pagato denaro al momento dell'acquisizione.

Il modulo non contiene risultati finanziari, previsioni o aggiornamenti operativi. Il modulo 144 indica solo l’intenzione di vendere e non garantisce l’esecuzione né implica nuove informazioni sui fondamentali di Viavi.

Viavi Solutions Inc. (VIAV) ha presentado un Formulario 144 informando que el ex CEO y actual presidente Richard E. Belluzzo tiene la intención de vender 8,385 acciones ordinarias a través de Morgan Stanley a partir del 01 de agosto de 2025. Según el valor de mercado declarado en el formulario, de 81.500 $, la venta propuesta representa aproximadamente el 0,0038 % de las 223,2 millones de acciones en circulación, haciendo que la transacción sea insignificante para el flotante público.

El aviso también detalla la actividad reciente de Belluzzo: en los últimos tres meses vendió 25,155 acciones en siete operaciones, generando aproximadamente 234,800 $ en ingresos brutos. Todas las acciones provienen de acciones restringidas otorgadas el 22 de febrero de 2017; no se pagó efectivo en la adquisición.

El formulario no contiene resultados financieros, pronósticos ni actualizaciones operativas. El Formulario 144 solo señala la intención de vender y no garantiza la ejecución ni implica nueva información sobre los fundamentos de Viavi.

Viavi Solutions Inc. (VIAV)� � CEO이자 � 회장� Richard E. Belluzzo가 2025� 8� 1� 이후 Morgan Stanley� 통해 8,385 보통주를 매도� 계획임을 알리� Form 144� 제출했습니다. 양식� 명시� 시장 가� 81,500달러� 기준으로 하면, 제안� 매도� 전체 발행 주식 2� 2,320� 주의 � 0.0038%� 해당하여 공공 유통 주식에는 미미� 영향입니�.

통지서에� Belluzzo� 최근 거래 내역� 포함되어 있습니다: 지� 3개월� 7건의 거래� 통해 25,155주를 매도하여 � 234,800달러� � 수익� 얻었습니�. 모든 주식은 2017� 2� 22일에 부여된 제한 주식에서 나왔으며, 취득 � 현금 지급은 없었습니�.

� 제출 서류에는 재무 실적, 전망 또는 운영 업데이트가 포함되어 있지 않습니다. Form 144� 단순� 매도 의사� 나타내며, 실행� 보장하거� Viavi� 기본 사항� 대� 새로� 정보� 의미하지 않습니다.

Viavi Solutions Inc. (VIAV) a déposé un formulaire 144 indiquant que l'ancien PDG et actuel président Richard E. Belluzzo prévoit de vendre 8 385 actions ordinaires via Morgan Stanley à partir du 1er août 2025. Selon la valeur de marché indiquée dans le formulaire, soit 81 500 $, la vente proposée représente environ 0,0038 % des 223,2 millions d'actions en circulation, rendant la transaction insignifiante pour le flottant public.

L'avis détaille également l'historique récent des transactions de Belluzzo : au cours des trois derniers mois, il a vendu 25 155 actions en sept transactions, générant environ 234 800 $ de produit brut. Toutes les actions proviennent d'actions restreintes attribuées le 22 février 2017 ; aucun paiement en espèces n'a été effectué lors de l'acquisition.

Le dépôt ne contient aucun résultat financier, prévision ou mise à jour opérationnelle. Le formulaire 144 signale uniquement une intention de vente et ne garantit pas l'exécution ni n'implique de nouvelles informations sur les fondamentaux de Viavi.

Viavi Solutions Inc. (VIAV) hat ein Formular 144 eingereicht, in dem der ehemalige CEO und aktuelle Vorsitzende Richard E. Belluzzo beabsichtigt, 8.385 Stammaktien über Morgan Stanley ab dem 01. August 2025 zu verkaufen. Basierend auf dem im Formular angegebenen Marktwert von 81.500 $ entspricht der geplante Verkauf etwa 0,0038 % der 223,2 Millionen ausstehenden Aktien, was die Transaktion für den Streubesitz unbedeutend macht.

Die Mitteilung enthält auch Belluzzos jüngste Handelsaktivitäten: In den letzten drei Monaten verkaufte er 25.155 Aktien in sieben Transaktionen und erzielte dabei einen Bruttoerlös von etwa 234.800 $. Alle Aktien stammen aus eingeschränkten Aktien, die am 22. Februar 2017 gewährt wurden; beim Erwerb wurde kein Geld bezahlt.

Die Einreichung enthält keine Finanzergebnisse, Prognosen oder betriebliche Updates. Formular 144 signalisiert lediglich die Verkaufsabsicht und garantiert weder die Ausführung noch impliziert es neue Informationen über die Fundamentaldaten von Viavi.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HOGAN JOSEPH M

(Last) (First) (Middle)
C/O ALIGN TECHNOLOGY INC.
410 NO. SCOTTSDALE RD., SUITE 1300

(Street)
TEMPE AZ 85281

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ALIGN TECHNOLOGY INC [ ALGN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
PRESIDENT AND CEO
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/01/2025 P 7,576 A $131.4851 184,945(1) D
Common Stock 55,267(1) I See Footnote(2)
Common Stock 1,500 I See Footnote(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects the Reporting Person's contribution of 55,267 shares to the Hogan 2025 GRAT dated May 31, 2025 ("Hogan 2025 GRAT").
2. Shares are held by the Hogan 2025 GRAT, for which the Reporting Person serves as trustee.
3. These securities are held directly by the spouse of the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or any other purpose.
/s/ Julie Ann Coletti, Attorney-in-Fact for Joseph Hogan 08/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Viavi (VIAV) shares does Richard E. Belluzzo plan to sell?

The Form 144 lists 8,385 common shares for potential sale.

What is the dollar value of the proposed insider sale?

At the disclosed market price, the sale is valued at approximately $81,500.

What percentage of Viavi’s outstanding shares does the sale represent?

About 0.0038 % of the company’s 223,236,654 shares outstanding.

Has the insider sold Viavi stock recently?

Yes. Over the past three months Belluzzo sold 25,155 shares for roughly $234.8 k in gross proceeds.

Does the Form 144 filing indicate any change in Viavi’s business outlook?

No. A Form 144 only discloses an intent to sell shares and provides no operational or financial guidance.
Align Technology Inc

NASDAQ:ALGN

ALGN Rankings

ALGN Latest News

ALGN Latest SEC Filings

ALGN Stock Data

14.76B
67.65M
6.67%
91.19%
5.13%
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
United States
TEMPE